Business Description
Jamjoom Pharmaceuticals Factory Co
ISIN : SA15QGU1UNH6
Compare
Compare
Traded in other countries / regions
4015.Saudi IPO Date
2023-06-20Description
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 99.49 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 3260.17 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 22.31 | |||||
Beneish M-Score | -1.58 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11 | |||||
3-Year EBITDA Growth Rate | 6.7 | |||||
3-Year EPS without NRI Growth Rate | 10.9 | |||||
3-Year FCF Growth Rate | 36.5 | |||||
3-Year Book Growth Rate | 6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.04 | |||||
9-Day RSI | 63.21 | |||||
14-Day RSI | 60.12 | |||||
6-1 Month Momentum % | 24.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.63 | |||||
Quick Ratio | 3.63 | |||||
Cash Ratio | 0.96 | |||||
Days Inventory | 161.4 | |||||
Days Sales Outstanding | 152.17 | |||||
Days Payable | 130.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.77 | |||||
Dividend Payout Ratio | 0.22 | |||||
Forward Dividend Yield % | 1.77 | |||||
5-Year Yield-on-Cost % | 1.77 | |||||
Shareholder Yield % | 1.77 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 63.63 | |||||
Operating Margin % | 29.73 | |||||
Net Margin % | 26.26 | |||||
FCF Margin % | 18.95 | |||||
ROE % | 22.69 | |||||
ROA % | 18.99 | |||||
ROIC % | 25.36 | |||||
ROC (Joel Greenblatt) % | 27.42 | |||||
ROCE % | 23.38 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.76 | |||||
PE Ratio without NRI | 30.95 | |||||
PS Ratio | 8.33 | |||||
PB Ratio | 6.75 | |||||
Price-to-Tangible-Book | 6.81 | |||||
Price-to-Free-Cash-Flow | 43.98 | |||||
Price-to-Operating-Cash-Flow | 35.33 | |||||
EV-to-EBIT | 28.67 | |||||
EV-to-EBITDA | 26.48 | |||||
EV-to-Revenue | 8.15 | |||||
EV-to-FCF | 43.02 | |||||
Price-to-Graham-Number | 3.06 | |||||
Price-to-Net-Current-Asset-Value | 13.34 | |||||
Earnings Yield (Greenblatt) % | 3.49 | |||||
FCF Yield % | 2.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jamjoom Pharmaceuticals Factory Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ï·¼) | 1,184.328 | ||
EPS (TTM) (ï·¼) | 4.44 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 60.12 | ||
14-Day ATR (ï·¼) | 3.93151 | ||
20-Day SMA (ï·¼) | 135.45 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (ï·¼) | 100.2 - 158.2 | ||
Shares Outstanding (Mil) | 70 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jamjoom Pharmaceuticals Factory Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jamjoom Pharmaceuticals Factory Co Stock Events
Event | Date | Price(ï·¼) | ||
---|---|---|---|---|
No Event Data |
Jamjoom Pharmaceuticals Factory Co Frequently Asked Questions
What is Jamjoom Pharmaceuticals Factory Co(SAU:4015)'s stock price today?
The current price of SAU:4015 is ï·¼141.00. The 52 week high of SAU:4015 is ï·¼158.20 and 52 week low is ï·¼100.20.
When is next earnings date of Jamjoom Pharmaceuticals Factory Co(SAU:4015)?
The next earnings date of Jamjoom Pharmaceuticals Factory Co(SAU:4015) is .
Does Jamjoom Pharmaceuticals Factory Co(SAU:4015) pay dividends? If so, how much?
The Dividend Yield %  of Jamjoom Pharmaceuticals Factory Co(SAU:4015) is 1.77% (As of Today), Highest Dividend Payout Ratio of Jamjoom Pharmaceuticals Factory Co(SAU:4015) was 0.24. The lowest was 0.22. And the median was 0.24. The  Forward Dividend Yield % of Jamjoom Pharmaceuticals Factory Co(SAU:4015) is 1.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |